Conditioned medium derived from mesenchymal stem cells overexpressing HPV16 E6E7 dramatically improves ischemic limb

Journal of Molecular and Cellular Cardiology

Volumn 72, Issue , 2014, Pages 339-349

  Chang, Ming Chau ^a,b   Tsao, Ching Hua ^b   Huang, Wei Hua ^a   Chih Hsueh Chen, Paul ^b   Hung, Shih Chieh ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Angiogenic factors; Marrow stromal cells; Multipotent stromal cells; Paracrine effects; PI3K AKT

Indexed keywords

INTERLEUKIN 1BETA; PROTEIN KINASE B; VASCULOTROPIN A; CULTURE MEDIUM; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PROTEIN E7; REPRESSOR PROTEIN; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CELL COUNT; CELL CULTURE; CELL MIGRATION; CELL TRANSFORMATION; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LIMB ISCHEMIA; LIMB PERFUSION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DISSECTION; DRUG EFFECTS; FEMORAL ARTERY; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; ISCHEMIA; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHARMACOLOGY; SECRETION (PROCESS); SURGERY; THIGH; VASCULARIZATION; VIROLOGY;

ANIMALS; CULTURE MEDIA, CONDITIONED; DISSECTION; FEMORAL ARTERY; GENE EXPRESSION; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTERLEUKIN-1BETA; ISCHEMIA; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; REPRESSOR PROTEINS; THIGH; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901320054     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.04.012     Document Type: Article

References (25)

1. Hung S.C., Pochampally R.R., Chen S.C., Hsu S.C., Prockop D.J. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 2007, 25:2363-2370.
2. Yew T.L., Hung Y.T., Li H.Y., Chen H.W., Chen L.L., Tsai K.S., et al. Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Cell Transplant 2010, 20:693-706.
3. Wang C.Y., Yang H.B., Hsu H.S., Chen L.L., Tsai C.C., Tsai K.S., et al. Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats. J Tissue Eng Regen Med 2012, 6:559-569.
4. Ratajczak MZ, Kucia M, Jadczyk T, Greco NJ, Wojakowski W, Tendera M, et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia.
5. Prockop D.J., Oh J.Y. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 2012, 20:14-20.
6. Prockop D.J. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther 2009, 17:939-946.
7. Tsai C.C., Chen Y.J., Yew T.L., Chen L.L., Wang J.Y., Chiu C.H., et al. Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood 2011, 117:459-469.
8. Wang X., Zhao T., Huang W., Wang T., Qian J., Xu M., et al. Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells 2009, 27:3021-3031.
9. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005, 11:367-368.
10. Hung S.C., Yang D.M., Chang C.F., Lin R.J., Wang J.S., Low-Tone Ho L., et al. Immortalization without neoplastic transformation of human mesenchymal stem cells by transduction with HPV16 E6/E7 genes. Int J Cancer 2004, 110:313-319.
11. Sekiya I., Larson B.L., Smith J.R., Pochampally R., Cui J.G., Prockop D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002, 20:530-541.
12. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004, 94:678-685.
13. Choi J.H., Hur J., Yoon C.H., Kim J.H., Lee C.S., Youn S.W., et al. Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. J Biol Chem 2004, 279:49430-49438.
14. Gnecchi M., He H., Noiseux N., Liang O.D., Zhang L., Morello F., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006, 20:661-669.
15. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
16. Matuoka K., Chen K.Y., Takenawa T. A positive role of phosphatidylinositol 3-kinase in aging phenotype expression in cultured human diploid fibroblasts. Arch Gerontol Geriatr 2003, 36:203-219.
17. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004, 109:1543-1549.
18. Prockop D.J. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther 2007, 82:241-243.
19. Baffour R., Garb J.L., Kaufman J., Berman J., Rhee S.W., Norris M.A., et al. Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J Surg Res 2000, 93:219-229.
20. Noiseux N., Gnecchi M., Lopez-Ilasaca M., Zhang L., Solomon S.D., Deb A., et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006, 14:840-850.
21. Fujio Y., Nguyen T., Wencker D., Kitsis R.N., Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000, 101:660-667.
22. Tateno K., Minamino T., Toko H., Akazawa H., Shimizu N., Takeda S., et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 2006, 98:1194-1202.
23. Deuse T., Peter C., Fedak P.W., Doyle T., Reichenspurner H., Zimmermann W.H., et al. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 2009, 120:S247-S254.
24. Tong Q., Zheng L., Lin L., Li B., Wang D., Huang C., et al. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kappaB signaling pathway. Respir Res 2006, 7:37.
25. Ojaniemi M., Glumoff V., Harju K., Liljeroos M., Vuori K., Hallman M. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol 2003, 33:597-605.